A Comprehensive Review of Behavioral Interventions for Weight Management in Schizophrenia

References

• Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults. JAMA 1999–2000; 2002(288):1723–1727
   Google Scholar
• Mokdad AIL Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289(1):76–79
   Google Scholar
• Homel P, Casey D, Allison DB: Changes in body mass index for individuals with and without schizophrenia, 1987-1996. Schizophr Res 2002; 55(3):277–284
   Google Scholar
• Allison DB, Fontaine KR, Heo M, Mentore IL, Cappelleri JC, Chandler LP, Weiden PJ, Cheskin LJ: The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999; 60(4):215–220
   PubMed Web of Science ®Google Scholar
• Meyer JM: Effects of atypical antipsychotics on weight and serum lipid levels. J Clin Psychiatry 2001; 62\(Suppl 27):27–34; discus-sion 40–41
   Google Scholar
• Davidson S, Judd F, Jolley D, Hocking B, Thompson S, Hyland B: Cardiovascular risk factors for people with mental illness. Aust N Z J Psychiatry 2001; 35(2):196–202
   PubMed Web of Science ®Google Scholar
• Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M, Lindenmayer JP, Manoukian SV, Banerji MA, Lebovitz HE, Hennekens CH: Antipsychotic-induced weight gain and metabolic abnormalities: Implications for increased mortality in patients with schizophrenia. J Clin Psychiatry 2004; 65\(Suppl 7):4–18; quiz 19–20
   Google Scholar
• Meyer JM: Awareness of obesity and weight issues among chron-ically mentally ill inpatients: A pilot study. Ann Clin Psychiatry 2002; 14(439–45
   Google Scholar
• Dixon L, Postrado L, Delahanty J, Fischer PJ, Lehman A: The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis 1999; 187(8):496–502
   PubMed Web of Science ®Google Scholar
• Kurzthaler I, Fleischhacker WW: The clinical implications of weight gain in schizophrenia. J Clin Psychiatry 2001; 62(Suppl 7):32–7
   PubMed Web of Science ®Google Scholar
• Allison DB, Mackell JA, McDonnell DD: The impact of weight gain on quality of life among persons with schizophrenia. Psychi-atr Serv 2003; 54(4):565–567
   Google Scholar
• Weiden PJ, Mackell JA, McDonnell DD: Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 2004; 66(1):51–57
   PubMed Web of Science ®Google Scholar
• Pandina G, Greenspan A, Bossie C, Turkoz I, Lonchena C, Morein J, Meyer JM: The metabolic syndrome in patients with schizophrenia. Abstract presented at the American Psychiatric Association Annual Meeting, New York City, May 5,2004
   Google Scholar
• Weiden PJ, Loebel A, Yang R, Lebovitz H: Course of weight & metabolic benefits 1 year after switching to ziprasidone. Abstract presented at American Psychiatric Association Annual Meeting, New York City, May 5,2004
   Google Scholar
• Werneke U, Taylor D, Sanders TA: Options for pharmacological management of obesity in patients treated with atypical antipsy-chotics. Int Clin Psychopharmacol 2002; 17(4):145–160
   Google Scholar
• Birt J: Management of weight gain associated with antipsychot-ics. Ann Clin Psychiatry 2003; 15(1):49–58
   Google Scholar
• Hamoui N, Kingsbury S, Anthone GJ, Crookes PF: Surgical treat-ment of morbid obesity in schizophrenic patients. Obes Surg 2004; 14(3):349–352
   PubMed Web of Science ®Google Scholar
• Aquila R: Management of weight gain in patients with schizo-phrenia. J Clin Psychiatry 2002; 63(Suppl 4):33–36
   PubMedGoogle Scholar
• Faulkner G, Soundy AA, Lloyd K: Schizophrenia and weight management: A systematic review of interventions to control weight. Acta Psychiatr Scand 2003; 108(5):324–332
   Google Scholar
• Werneke U, Taylor D, Sanders TA, Wessely S: Behavioural man-agement of antipsychotic-induced weight gain: A review. Acta Psychiatr Scand 2003; 108(4):252–259
   PubMed Web of Science ®Google Scholar
• Feeney L, Dempsey J, Moynihan F, Barry S: Changes in body mass indices of patients with schizophrenia 3 years following the introduction of a weight management programme. Jr Med J2003; 96(9):276–277
   Google Scholar
• Klein B, Simon WE, Steele RL, Primavera LH: Reinforcement and weight loss in schizophrenics. Psychol Rep 1972; 30(2):581–582
   Google Scholar
• Knox JM: A study of weight reducing diets in psychiatric in-patients. Br J Psychiatry 1980; 136:287–289
   PubMed Web of Science ®Google Scholar
• Nguyen CT, Yu B, Maguire G: Update on atypicals: Preemptive tactics to reduce weight gain. Curr Psychiatry Online 2003; 2(3)
   Google Scholar
• Aquila R, Emanuel M: Interventions for weight gain in adults treated with novel antipsychotics. Prim Care Companion. J Clin Psychiatry 2000; 2(1):20–23
   PubMedGoogle Scholar
• Merriman S, Riddell D, Thrush N: Wonderful me!: Evaluation of multidisciplinary therapy package for overweight psychiatric patients. Br J Ther Rehab 1995; 2(10):531–535
   Google Scholar
• Ball MP, Coons VB, Buchanan RW: A program for treating olanzapine-related weight gain. Psychiatr Serv 2001; 52(7):967–969
   PubMed Web of Science ®Google Scholar
• Umbricht D, Flury H, Bridler R: Cognitive behavior therapy for weight gain. Am J Psychiatry 2001; 158(6):971
   Google Scholar
• Archie S, Wilson JH, Osborne S, Hobbs H, McNiven J: Pilot study: access to fitness facility and exercise levels in olanzapine-treated patients. Can J Psychiatry 2003; 48(9):628–632
   PubMed Web of Science ®Google Scholar
• O'Keefe CD, Noordsy DL, Liss TB, Weiss H: Reversal of anti-psychotic-associated weight gain. J Clin Psychiatry 2003; 64(8):907–912
   Google Scholar
• Vreeland B, Minsky S, Menza M, Rigassio Radler D, Roemheld-Hamm B, Stern R: A program for managing weight gain associ-ated with atypical antipsychotics. Psychiatr Serv 2003; 54(8):1155–1157
   PubMed Web of Science ®Google Scholar
• Menza M, Vreeland B, Minsky S, Gara M, Radler DR Sakowitz M: Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry 2004; 65(4):471–477
   PubMed Web of Science ®Google Scholar
• Ayllon T: Intensive treatment of psychotic behaviour by stimulus satiation and food reinforcement. Behav Res Ther 1963; 21:53–61
   Google Scholar
• Sletten I, Cazenave M, Gershon S: Effects of caloric restriction on behavior and body weight during chlorpromazine therapy. Dis Nerv Syst 1967; 28(8):519–522
   Google Scholar
• Bernard JL: Rapid treatment of gross obesity by operant tech-niques. Psychol Rep 1968; 23(2):663–666
   Google Scholar
• Harmatz MG, Lapuc P: Behavior modification of overeating in a psychiatric population. J Consult Clin Psychol 1968; 32(5):583–587
   PubMedGoogle Scholar
• Moore CH, Crum BC: Weight reduction in a chronic schizo-phrenic by means of operant conditioning procedures: A case study. Behav Res Ther 1969; 7:129–131
   PubMed Web of Science ®Google Scholar
• Upper D, Newton JG: A weight-reduction program for schizo-phrenic patients on a token economy unit: Two case studies. J Behav Ther Experi Psychiatry 1971; 2:113–115
   Web of Science ®Google Scholar
• Heimberg C, Gallacher F, Gur R, et al.: Diet and gender moderate clozapine-related weight gain. Human Psychopharmacology 1995; 10:367–371
   Google Scholar
• Rotatori AF, Fox R, Wicks A: Weight loss with psychiatric resi-dents in a behavioral self control program. Psychol Rep 1980; 46:483–486
   PubMed Web of Science ®Google Scholar
• Wirshing DA, Wishing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J, Mintz J, Marder SR: Novel antipsychotics: Compar-ison of weight gain liabilities. J Clin Psychiatry 1999; 60(6):358–363
   PubMed Web of Science ®Google Scholar
• Littrell KH, Hilligoss NM, Kirshner CD, Petty RG, Johnson CG: The effects of an educational intervention on antipsychotic-induced weight gain. J Nurs Scholarsh 2003; 35(3):237–241
   PubMed Web of Science ®Google Scholar
• Ohlsen RI, Treasure J, Pilowsky LS: A dedicated nurse-led ser-vice for antipsychotic-induced weight gain. Psychiatr Bull 2004; 28:164–166
   Google Scholar
• Ried LD, Renner BT, Bengtson MA, Wilcox BM, Acholonu WW, Jr.: Weight change after an atypical antipsychotic switch. Ann Pharmacother 2003; 37(10) : 1381–1386
   Google Scholar
• Cohen S, Glazewski R, Khan S, Khan A: Weight gain with ris-peridone among patients with mental retardation: effect of calorie restriction. J Clin Psychiatry 2001; 62(2): 114–116
   Google Scholar
• National Heart Lung and Blood Institute: Identification, evalua-tion and treatment of overweight and obesity in adults, US Department of Health and Human Services, 2000
   Google Scholar